Business

Mankind Pharma IPO Opens to a Slow Start, Subscribed Only 6% on Day 1

Mankind Pharma’s IPO was in news since a couple of days. On the first day which is Tuesday, it had a subscription rate of 6% at the time of writing the news as the investors stayed on the sidelines. The non-institutional investors (NIIs) accounted for about 7% of the subscription, while the retail investors subscribed to approximately 5% of their allotted quota. As per data available on BSE, the company has received bids for 10,94,145 shares against the total offer of 2,80,41,192 shares.

Bids for the QIBs’ portion of the shares on offer for this segment amounted to 1,170 shares against the total of 80,11,769 shares. Similarly, the non-institutional investors’ portion received bids for 4,48,591 shares out of the total of 60,08,827 shares on offer for this segment.

Also Read: Britain Set to Challenge Google, Amazon and Facebook With Enhanced Legal Powers

Bids for the retail investors’ portion of shares on offer for this segment amounted to 6,44,384 shares, while the total number of shares on offer for this segment was 1,40,20,596. On the other hand, no subscriptions were made for the employees’ portion.

Mankind Pharma’s IPO opened for subscription on April 25 and will close on April 27. The price band for the proposed initial public offer has been set at ₹1,026 to ₹1,080 per equity share. The public offering consists of an offer-for-sale (OFS) of 40,058,844 equity shares by the existing shareholders and promoters. Each equity share has a face value of ₹1.

Also Read: Tata Consumer Products To Nestle India, Companies to Announce Results Today

At the upper end of the price range, the company aims to raise a maximum of ₹4,326.36 crore through the IPO. The IPO is being conducted through the book-building process, where non-institutional investors must be offered at least 15% of the total offer, retail individual investors must be offered at least 35%, and a maximum of 50% can be allocated to qualified institutional buyers.

Kotak Mahindra Capital Company Ltd, Axis Capital Ltd, IIFL Securities Ltd, Jefferies India Private Ltd, and JP Morgan India Private Ltd are the book-running lead managers (BRLMs) for the Mankind Pharma IPO. The registrar for the IPO is KFin Technologies Ltd. The shares are expected to be listed on both BSE and NSE on Monday, May 8.

(This is a developing story)

Shruti Rag

Recent Posts

In The Era Of AI, Reforming Global Institutions Is Critical: PM Modi

PM Modi, at BRICS, called for global reforms, a multipolar order, and India’s AI leadership…

5 hours ago

PM Modi Criticises Outdated Global Institutions; Urges Reform At BRICS Summit In Brazil

PM Modi strongly criticised outdated global institutions like the UN Security Council and WTO during…

5 hours ago

A View Like No Other: Shubhanshu Shukla’s Space Photos Highlight ‘India Among The Stars’

Group Captain Shubhanshu Shukla makes history as the first Indian aboard the ISS, marking a…

6 hours ago

Ramdas Athawale Slams Raj Thackeray Over Language Row; Urges Strict Action Against Violence

Union Minister Ramdas Athawale condemned MNS chief Raj Thackeray for inciting violence over language issues…

7 hours ago

Samsung Galaxy Watch 8 & Watch 8 Classic Specs Leak: What To Expect

Detailed specs and pricing for Samsung’s Galaxy Watch 8 and Classic have leaked, highlighting improved…

9 hours ago

Kareena Kapoor Calls Out Prada Over Kolhapuri Chappal Design Controversy

Kareena Kapoor shared a subtle yet pointed message on Instagram, showcasing her original Kolhapuri chappals…

9 hours ago